FLVCR2 and Parkinson disease: In addition to the aggregation of the huntingtin protein being modulated by CCT, CCT oligomer can also prevent the Parkinson’s disease-causing A53T mutant of α-synuclein and wild-type α-synuclein from aggregating in the presence of either ATP or ADP (Sot et al., 2017).